Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 169

1.

Changing the South African national antiretroviral therapy guidelines: The role of cost modelling.

Meyer-Rath G, Johnson LF, Pillay Y, Blecher M, Brennan AT, Long L, Moultrie H, Sanne I, Fox MP, Rosen S.

PLoS One. 2017 Oct 30;12(10):e0186557. doi: 10.1371/journal.pone.0186557. eCollection 2017.

2.

Varying intervals of antiretroviral medication dispensing to improve outcomes for HIV patients (The INTERVAL Study): study protocol for a randomized controlled trial.

Hoffman R, Bardon A, Rosen S, Fox M, Kalua T, Xulu T, Taylor A, Sanne I.

Trials. 2017 Oct 13;18(1):476. doi: 10.1186/s13063-017-2177-z.

3.

Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.

Badal-Faesen S, Firnhaber C, Kendall MA, Wu X, Grinsztejn B, Escada RODS, Fernandez M, Hogg E, Sanne I, Johnson P, Alland D, Mazurek GH, Benator DA, Luetkemeyer AF; AIDS Clinical Trials Group A5295; Tuberculosis Trials Consortium Study 34 Teams.

J Clin Med. 2017 Aug 7;6(8). pii: E78. doi: 10.3390/jcm6080078.

4.

Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial.

Belaunzarán-Zamudio PF, Azzoni L, Canaday DH, Caro-Vega YN, Clagget B, Rassool MS, Rodriguez B, Sanne I, Sereti I, Sierra-Madero JG, Lederman MM.

Pathog Immun. 2017;2(2):151-177. doi: 10.20411/pai.v2i2.181. Epub 2017 May 9.

5.

Cohort profile: the Right to Care Clinical HIV Cohort, South Africa.

Fox MP, Maskew M, Brennan AT, Evans D, Onoya D, Malete G, MacPhail P, Bassett J, Ebrahim O, Mabotja D, Mashamaite S, Long L, Sanne I.

BMJ Open. 2017 Jun 10;7(6):e015620. doi: 10.1136/bmjopen-2016-015620.

6.

Multidisciplinary Point-of-Care Testing in South African Primary Health Care Clinics Accelerates HIV ART Initiation but Does Not Alter Retention in Care.

Stevens WS, Gous NM, MacLeod WB, Long LC, Variava E, Martinson NA, Sanne I, Osih R, Scott LE.

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):65-73. doi: 10.1097/QAI.0000000000001456.

PMID:
28542080
7.

Initiating antiretroviral therapy for HIV at a patient's first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial.

Long LC, Maskew M, Brennan AT, Mongwenyana C, Nyoni C, Malete G, Sanne I, Fox MP, Rosen S.

AIDS. 2017 Jul 17;31(11):1611-1619. doi: 10.1097/QAD.0000000000001528.

PMID:
28463879
8.

Client uptake of safer conception strategies: implementation outcomes from the Sakh'umndeni Safer Conception Clinic in South Africa.

Schwartz SR, Bassett J, Holmes CB, Yende N, Phofa R, Sanne I, Van Rie A.

J Int AIDS Soc. 2017 Mar 8;20(Suppl 1):21291. doi: 10.7448/IAS.20.2.21291.

9.

Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients.

Manion M, Andrade BB, DerSimonian R, Gu W, Rupert A, Musselwhite LW, Sierra-Madero JG, Belaunzaran-Zamudio PF, Sanne I, Lederman MM, Sereti I.

J Virus Erad. 2017 Jan 1;3(1):24-33.

10.

Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South Africa.

Shearer K, Clouse K, Meyer-Rath G, MacLeod W, Maskew M, Sanne I, Long L, Fox MP.

BMJ Open. 2017 Jan 24;7(1):e013908. doi: 10.1136/bmjopen-2016-013908.

11.

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.

Boeree MJ, Heinrich N, Aarnoutse R, Diacon AH, Dawson R, Rehal S, Kibiki GS, Churchyard G, Sanne I, Ntinginya NE, Minja LT, Hunt RD, Charalambous S, Hanekom M, Semvua HH, Mpagama SG, Manyama C, Mtafya B, Reither K, Wallis RS, Venter A, Narunsky K, Mekota A, Henne S, Colbers A, van Balen GP, Gillespie SH, Phillips PPJ, Hoelscher M; PanACEA consortium.

Lancet Infect Dis. 2017 Jan;17(1):39-49. doi: 10.1016/S1473-3099(16)30274-2. Epub 2016 Oct 26.

12.

Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study.

Maskew M, Bor J, Hendrickson C, MacLeod W, Bärnighausen T, Pillay D, Sanne I, Carmona S, Stevens W, Fox MP.

BMC Health Serv Res. 2017 Jan 17;17(1):41. doi: 10.1186/s12913-016-1940-2.

13.

Evaluation of the Tsima community mobilization intervention to improve engagement in HIV testing and care in South Africa: study protocol for a cluster randomized trial.

Lippman SA, Pettifor A, Rebombo D, Julien A, Wagner RG, Kang Dufour MS, Kabudula CW, Neilands TB, Twine R, Gottert A, Gómez-Olivé FX, Tollman SM, Sanne I, Peacock D, Kahn K.

Implement Sci. 2017 Jan 17;12(1):9. doi: 10.1186/s13012-016-0541-0.

14.

Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.

Long LC, Rosen SB, Brennan A, Moyo F, Sauls C, Evans D, Modi SL, Sanne I, Fox MP.

PLoS One. 2016 Dec 12;11(12):e0168118. doi: 10.1371/journal.pone.0168118. eCollection 2016.

15.

Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa.

Steegen K, Bronze M, Papathanasopoulos MA, van Zyl G, Goedhals D, Van Vuuren C, Macleod W, Sanne I, Stevens WS, Carmona SC.

J Infect Dis. 2016 Dec 15;214(12):1826-1830. Epub 2016 Oct 20.

PMID:
27923946
16.

Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.

Steegen K, Carmona S, Bronze M, Papathanasopoulos MA, van Zyl G, Goedhals D, MacLeod W, Sanne I, Stevens WS.

PLoS One. 2016 Dec 1;11(12):e0166305. doi: 10.1371/journal.pone.0166305. eCollection 2016.

17.

Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa.

Brennan AT, Bor J, Davies MA, Conradie F, Maskew M, Long L, Sanne I, Fox MP.

Trop Med Int Health. 2017 Feb;22(2):241-251. doi: 10.1111/tmi.12811. Epub 2016 Dec 26.

PMID:
27862762
18.

Prevalence of latent tuberculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional study.

Ncayiyana JR, Bassett J, West N, Westreich D, Musenge E, Emch M, Pettifor A, Hanrahan CF, Schwartz SR, Sanne I, van Rie A.

BMC Infect Dis. 2016 Nov 8;16(1):661.

19.

Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study.

Berhanu R, Schnippel K, Mohr E, Hirasen K, Evans D, Rosen S, Sanne I.

PLoS One. 2016 Nov 3;11(11):e0164974. doi: 10.1371/journal.pone.0164974. eCollection 2016.

20.

Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort.

Balagopal A, Gupte N, Shivakoti R, Cox AL, Yang WT, Berendes S, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Lama JR, Cardoso SW, Sugandhavesa P, Semba RD, Hakim J, Hosseinipour MC, Kumarasamy N, Sanne I, Asmuth D, Campbell T, Bollinger RC, Gupta A.

Open Forum Infect Dis. 2016 Jul 27;3(3):ofw118. eCollection 2016 Sep.

Supplemental Content

Loading ...
Support Center